Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
49.30
-1.40 (-2.76%)
At close: Jun 2, 2026, 4:00 PM EDT
51.00
+1.70 (3.45%)
After-hours: Jun 2, 2026, 7:38 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $133.22 million as of June 2, 2026. Its market cap has increased by 4,686.93% in one year.
Market Cap
133.22M
Enterprise Value
85.94M
1-Year Change
4,686.93%
Ranking
Category
Stock Price
$49.30
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $133.22M, a decrease of -64.80%. That is a compound annual growth rate of -16.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 137.01M | 46.94% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 150.29M |
| Corbus Pharmaceuticals Holdings | 146.55M |
| Kazia Therapeutics | 146.04M |
| Agenus | 145.38M |
| TuHURA Biosciences | 143.92M |
| Genelux | 135.45M |
| Alpha Cognition | 134.78M |
| Cardiff Oncology | 129.90M |